These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 22958947)

  • 1. Allergic symptoms after pandemic influenza vaccination rarely mediated by vaccine-specific IgE.
    Rouleau I; De Serres G; Drolet JP; Banerjee D; Lemire C; Moore A; Paradis L; Alizadhefar R; Des Roches A; Chan ES; Stark D; Benoit M; Skowronski DM;
    J Allergy Clin Immunol; 2012 Dec; 130(6):1423-6. PubMed ID: 22958947
    [No Abstract]   [Full Text] [Related]  

  • 2. Effectiveness of vaccine against pandemic influenza A/H1N1 among people with underlying chronic diseases: cohort study, Denmark, 2009-10.
    Emborg HD; Krause TG; Hviid A; Simonsen J; Mølbak K
    BMJ; 2011 Jan; 344():d7901. PubMed ID: 22277542
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pandemic 2009 influenza H1N1 virus vaccination: compliance and safety in a single hemodialysis center.
    Stavroulopoulos A; Stamogiannos G; Aresti V
    Ren Fail; 2010; 32(9):1044-8. PubMed ID: 20863207
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Attitudes and side effects related to pandemic influenza A (H1N1) vaccination in healthcare personnel].
    Ormen B; Türker N; Vardar I; Kaptan F; El S; Ural S; Kaya F; Coşkun NA
    Mikrobiyol Bul; 2012 Jan; 46(1):57-64. PubMed ID: 22399172
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The safety of the H1N1 influenza A vaccine in egg allergic individuals.
    Greenhawt MJ; Chernin AS; Howe L; Li JT; Sanders G
    Ann Allergy Asthma Immunol; 2010 Nov; 105(5):387-93. PubMed ID: 21055666
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety of influenza A (H1N1) vaccine in postmarketing surveillance in China.
    Liang XF; Li L; Liu DW; Li KL; Wu WD; Zhu BP; Wang HQ; Luo HM; Cao LS; Zheng JS; Yin DP; Cao L; Wu BB; Bao HH; Xu DS; Yang WZ; Wang Y
    N Engl J Med; 2011 Feb; 364(7):638-47. PubMed ID: 21288090
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serious adverse reactions should be further monitored after influenza A (H1N1) vaccination among children: postmarketing experience with 570,000 vaccinations between October 2009 and August 2010 in Guangzhou, China.
    Fu C; Xu J; Tan H; Wang M
    Pediatr Infect Dis J; 2011 Jul; 30(7):631-2. PubMed ID: 21673552
    [No Abstract]   [Full Text] [Related]  

  • 8. [Pandemic vaccines].
    Floret D
    Arch Pediatr; 2010 Jun; 17(6):906-7. PubMed ID: 20654954
    [No Abstract]   [Full Text] [Related]  

  • 9. [Pandemic influenza A (H1N1)v vaccination status and factors affecting vaccination: Ankara and Diyarbakır 2009 data from Turkey].
    Ertek M; Sevencan F; Kalaycıoğlu H; Gözalan A; Simşek C; Culha G; Dorman V; Ozlü A; Arıkan F; Aktaş D; Akın L; Korukluoğlu G; Sevindi DF
    Mikrobiyol Bul; 2011 Oct; 45(4):684-96. PubMed ID: 22090299
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effectiveness of the monovalent influenza A(H1N1)2009 vaccine in Navarre, Spain, 2009-2010: cohort and case-control study.
    Castilla J; Morán J; Martínez-Artola V; Fernández-Alonso M; Guevara M; Cenoz MG; Reina G; Alvarez N; Arriazu M; Elía F; Salcedo E; Barricarte A;
    Vaccine; 2011 Aug; 29(35):5919-24. PubMed ID: 21723358
    [TBL] [Abstract][Full Text] [Related]  

  • 11. No effect of 2008/09 seasonal influenza vaccination on the risk of pandemic H1N1 2009 influenza infection in England.
    Pebody R; Andrews N; Waight P; Malkani R; McCartney C; Ellis J; Miller E
    Vaccine; 2011 Mar; 29(14):2613-8. PubMed ID: 21292008
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Active surveillance of adverse events following immunization against pandemic influenza A (H1N1) in Korea.
    Choe YJ; Cho H; Song KM; Kim JH; Han OP; Kwon YH; Bae GR; Lee HJ; Lee JK
    Jpn J Infect Dis; 2011; 64(4):297-303. PubMed ID: 21788704
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety monitoring of Influenza A/H1N1 pandemic vaccines in EudraVigilance.
    Kurz X; Domergue F; Slattery J; Segec A; Szmigiel A; Hidalgo-Simon A
    Vaccine; 2011 Jun; 29(26):4378-87. PubMed ID: 21501644
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safe vaccination of patients with egg allergy with an adjuvanted pandemic H1N1 vaccine.
    Gagnon R; Primeau MN; Des Roches A; Lemire C; Kagan R; Carr S; Ouakki M; Benoît M; De Serres G;
    J Allergy Clin Immunol; 2010 Aug; 126(2):317-23. PubMed ID: 20579720
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibody response after a single dose of an AS03-adjuvanted split-virion influenza A (H1N1) vaccine in heart transplant recipients.
    Meyer S; Adam M; Schweiger B; Ilchmann C; Eulenburg C; Sattinger E; Runte H; Schlüter M; Deuse T; Reichenspurner H; Costard-Jäckle A
    Transplantation; 2011 May; 91(9):1031-5. PubMed ID: 21358365
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pandemic 2009 H1N1 influenza virus vaccination in lung transplant recipients: coverage, safety and clinical effectiveness in the Zurich cohort.
    Schuurmans MM; Tini GM; Dalar L; Fretz G; Benden C; Boehler A
    J Heart Lung Transplant; 2011 Jun; 30(6):685-90. PubMed ID: 21444211
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acceptance of a vaccine against pandemic influenza A (H1N1) virus amongst healthcare workers in Beijing, China.
    Seale H; Kaur R; Wang Q; Yang P; Zhang Y; Wang X; Li X; Zhang H; Zhang Z; MacIntyre CR
    Vaccine; 2011 Feb; 29(8):1605-10. PubMed ID: 21211593
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [IgE-response after administration of pandemic vaccine strain A/California/7/2009 (H1N1)v].
    Kostinov MP; Terkacheva OA; Zhirova SN; Cherdanchev AP; Erofeeva MK
    Vestn Ross Akad Med Nauk; 2012; (10):44-8. PubMed ID: 23240499
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monitoring pandemic influenza A(H1N1) vaccination coverage in Germany 2009/10 - results from thirteen consecutive cross-sectional surveys.
    Walter D; Böhmer MM; Heiden Ma; Reiter S; Krause G; Wichmann O
    Vaccine; 2011 May; 29(23):4008-12. PubMed ID: 21463683
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vaccine safety.
    Labadie J
    Int J Risk Saf Med; 2011; 23(2):113-5. PubMed ID: 21673419
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.